Evidence map›Paper›PMID 30563119›Full record

SynthesisNutrients2018

Selenium and Type 2 Diabetes: Systematic Review.

Lindsay N Kohler, Janet Foote, Connor P Kelley, Ana Florea, Colleen Shelly, H-H Sherry Chow, Paul Hsu, Ken Batai, Nathan Ellis, Kathylynn Saboda and 2 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Selenium-enrichedFrontiers in fungal biology · 2026
    Article
  7. Selenium status markers and their relationship with anthropometric, glycemic, and inflammatory variables in institutionalized older adults.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Lindsay N KohlerDepartment of Health Promotion Sciences, Mel and Enid College of Public Health, University of Arizona, Tucson, AZ 85724, USA. lschulz@email.arizona.edu.
Janet FooteDepartment of Epidemiology, Mel and Enid College of Public Health, University of Arizona, Tucson, AZ 85724, USA. jfoote@email.arizona.edu.
Connor P KelleyDepartment of Epidemiology, Mel and Enid College of Public Health, University of Arizona, Tucson, AZ 85724, USA. cpkelley@email.arizona.edu.
Ana FloreaDepartment of Epidemiology, Mel and Enid College of Public Health, University of Arizona, Tucson, AZ 85724, USA. aflorea@email.arizona.edu.ORCID 0000-0003-0030-8737
Colleen ShellyDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA. colleenshelly@gmail.com.
H-H Sherry ChowDepartment of Medicine, University of Arizona Cancer Center, Tucson, AZ 85724, USA. schow@email.arizona.edu.
Paul HsuDepartment of Epidemiology, Mel and Enid College of Public Health, University of Arizona, Tucson, AZ 85724, USA. pchhsu@email.arizona.edu.
Ken BataiDepartment of Surgery, University of Arizona, Tucson, AZ 85724, USA. kbatai@email.arizona.edu.
Nathan EllisDepartment of Medicine, University of Arizona Cancer Center, Tucson, AZ 85724, USA. naellis@email.arizona.edu.ORCID 0000-0003-4231-502X
Kathylynn SabodaDepartment of Medicine, University of Arizona Cancer Center, Tucson, AZ 85724, USA. ksaboda@email.arizona.edu.
Peter LanceDepartment of Medicine, University of Arizona, Tucson, AZ 85724, USA. plance@uacc.arizona.edu.
Elizabeth T JacobsDepartment of Epidemiology, Mel and Enid College of Public Health, University of Arizona, Tucson, AZ 85724, USA. jacobse@email.arizona.edu.
University of Arizona · USHarvard University · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
Selenium Colorectal Cancer Chemoprevention TrialsR01CA151708 · NCI · UNIVERSITY OF ARIZONA · PI JACOBS, ELIZABETH T · 2011 to 2021
$6.8M
National Cancer Institute P30 CA023074National Institutes of Health P01 CA041108National Institutes of Health R01CA151708NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA151708
6 · The paper itself

Abstract

Several studies have investigated the potential role of selenium (Se) in the development of type 2 diabetes (T2D) with disparate findings. We conducted a systematic review and meta-analysis to synthesize the evidence of any association between Se and T2D. PubMed, Embase, and Scopus were searched following the Preferred Reporting Items for Systematic Reviews and Meta-analysis Approach (PRISMA). Sixteen studies from 15 papers met inclusion criteria defined for this review. Of the 13 observational studies included, 8 demonstrated a statistically significant positive association between concentrations of Se and odds for T2D, with odds ratios (95% confidence intervals) ranging from 1.52 (1.01⁻2.28) to 7.64 (3.34⁻17.46), and a summary odds ratio (OR) (95% confidence interval (CI)) of 2.03 (1.51⁻2.72). In contrast, among randomized clinical trials (RCTs) of Se, a higher risk of T2D was not observed for those who received Se compared to a placebo (OR = 1.18, 95% CI 0.95⁻1.47). Taken together, the results for the relationship between Se and T2D differ between observational studies and randomized clinical trials (RCTs). It remains unclear whether these differences are the result of uncontrolled confounding in the observational studies, or whether there is a modest effect of Se on the risk for T2D that may vary by duration of exposure. Further investigations on the effects of Se on glucose metabolism are needed.

Indexed as

Diabetes Mellitus, Type 2HumansOdds RatioRisk FactorsSeleniumSeleniumglucoseinsulin resistancereviewseleniumselenium supplementationtype 2 diabetes

Identifiers

PMID30563119
PMCPMC6316380
OpenAlexW2902434282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.